Fernando M. Rodrigues - 28 Feb 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President of BetterHelp
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
28 Feb 2025
Net transactions value
-$18,719
Form type
4
Filing time
04 Mar 2025, 16:07:22 UTC
Previous filing
03 Dec 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +5,491 5,491 28 Feb 2025 Direct F1
transaction TDOC Common Stock Sale $18,719 -1,933 -35% $9.68 3,558 03 Mar 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -5,491 -12% $0.000000 38,439 28 Feb 2025 Common Stock 5,491 Direct F1, F3
transaction TDOC Restricted Stock Units Award $0 +104,602 $0.000000 104,602 01 Mar 2025 Common Stock 104,602 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F4 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F5 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.